Citius Oncology (CTOR) Cash from Operations (2023 - 2026)

Citius Oncology's Cash from Operations history runs 4 years deep, the most recent figure standing at 3831618.0 for Q1 2026.

• In Q1 2026, Cash from Operations changed N/A year-over-year to 3831618.0; the TTM figure through Mar 2026 stood at 11744360.0 (changed N/A YoY), while the FY2025 annual figure was 5492046.0, down 4446.59% from the prior year.
• Cash from Operations was 3831618.0 for Q1 2026 at Citius Oncology, up from 7354946.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 100256.0 in Q2 2023 to a low of 7354946.0 in Q4 2025.
• Historically, Cash from Operations has averaged 1770848.86 across 4 years, with a median of 366106.0 in 2024.
• Biggest YoY gain for Cash from Operations was 13.56% in 2024; the steepest drop was 265.17% in 2024.
• A 4-year view of Cash from Operations shows it stood at 382527.0 in 2023, then increased by 4.29% to 366106.0 in 2024, then sank by 1908.97% to 7354946.0 in 2025, then jumped by 47.9% to 3831618.0 in 2026.
• The last three Cash from Operations figures came in at 3831618.0 (Q1 2026), 7354946.0 (Q4 2025), and 366106.0 (Q2 2024), per Business Quant data.